TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.

Franz J Legat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.